Agilent Technologies Inc vs Teucrium Wheat Fund — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Teucrium Wheat Fund trades at $23.69. The key difference: Agilent Technologies Inc pays a 0.69% dividend while Teucrium Wheat Fund pays none, and Agilent Technologies Inc is trading nearer its 52-week high, Teucrium Wheat Fund nearer its low. Which is the better fit depends on your goals.
| A | WEAT | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $157.20 | $26.00 |
52-Week Low | $110.24 | $19.88 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
WEAT, the Teucrium Wheat Fund, trades at $23.91, up 0.8% on the day, with a neutral technical signal overall. Recent performance shows strength, gaining 9.9% over the past month and 25% year-to-date as of July 21, 2026 (Zacks Investment Research). Key support and resistance cluster around $24, while oscillators like the relative strength index indicate neutral momentum. The USDA's reduced wheat production outlook for 2026 to 1.56 billion bushels, below analyst expectations (WSJ, May 12, 2026), underscores supply-side influences.
Outlook remains tied to agricultural commodity cycles; inflation trends and crop forecasts drive volatility. Risks include weather disruptions and global demand shifts, but current sentiment is balanced with potential for further gains if supply constraints persist.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →